Good Therapeutics, Inc.

Biotechnology ResearchWashington, United States0-1 Employees

Good Therapeutics, Inc. is a biotechnology company based in Seattle, Washington, focused on developing protein-based medicines with regulated, context-dependent activity. Its approach aims to create drugs that respond to their local environment by shifting from an inactive to an active state, with the ability to revert when the activating signal is no longer present, a mechanism rooted in allosteric control of protein activity. The company targets cancer and other diseases, seeking to apply its technology to therapies that act specifically where needed in the body. Positioned within the biotechnology research sector, Good Therapeutics has progressed from early financing to strategic developments and collaboration-focused advancement, including an initiative begun to translate its technology through a subsidiary. The organization operates with a small team and is part of a broader landscape of firms pursuing advanced biotherapeutics, with a history of leadership and organizational changes over recent years.

Sign up for free to view info

Email Format Employee directory